Biogen & TheraPanacea Announce New Collaboration with the Potential to Advance Digital Health for Personalized Medicine in Neuroscience

December 14, 2021 - 13:00 CET
The aim is to develop innovative machine learning and artificial intelligence solutions for personalized and earlier treatment in neurology. Biogen will get exclusive rights to TheraPanacea AI technology in neuroscience

Read More


ASTRO2021-TheraPanacea-LandingPage

ASTRO 2021

Read More


SFRO 2021

Read More


Landing-Page-TheraPanacea-DGMP-2021

DGMP 2021

Read More